FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

KVK-Tech HydrOXYzine HCI Tablets 25 mg Recall

HydrOXYzine HCI Tablets USP 25 mg, 100, 500, and 1000 count bottles, Rx only

KVK-Tech, Inc. · Newtown, PA

Risk level
Class II
Reported by FDA
Jan 29, 2014
Recall ID
D-1031-2014
Check your lot numberHow we source this data

Summary

KVK-Tech recalled HydrOXYzine HCI Tablets 25 mg starting Dec 11, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1031-2014 on Jan 29, 2014. Reason: Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source. Status: Terminated.

Why it was recalled

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Product description

HydrOXYzine HCI Tablets USP 25 mg, 100, 500, and 1000 count bottles, Rx only. Mfd by: KVK-TECH, INC, Newtown, PA 18940. 100 count NDC: 10702-011-01, 500 count NDC: 10702-011-50, 1000 count NDC: 10702-011-10.

Lot numbers, UPCs & expiration codes

NDC: 10702-011-01: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot # 10789, exp.May-14; lot #10790, exp. Jun-14; lot # 10791, exp. Jun-14: lot # 10792, exp. Aug-14; lot #10983, exp. Sep-14; lot #10984, exp.Sep-14; lot #10986, exp. Oct-14; lot # 11034, exp. Nov-14; lot #11035, exp. Dec-14; lot # 11036, exp. Dec-14; lot #11435, exp. Nov-15. NDC: 10702-011-10: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot #10789, exp. May-14; lot #10790, exp. Jun-14; lot #10791, exp. Jun-14; lot #10792, exp. Aug-14; lot # 10983, exp. Sep-14; lot #10985, exp. Oct-14; lot #11034, exp. Nov-14; lot #11038, exp. Dec-14; lot #11435, exp. Nov-15. NDC: 10702-011-50: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot # 10789, exp. May-14; lot #10791, exp. Jun-14; lot# 10792, exp. Aug-14; lot # 10983, exp. Sep-14; lot # 10985, exp. Oct-14; lot # 10986, exp. Oct-14; lot # 11037, exp. Dec-14; lot #11435, exp. Nov-15.

Where it was sold

Nationwide, including Puerto Rico to wholesale distributors for sale to retail establishments.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1031-2014
Classification
Class II
Status
Terminated
Recall initiated
Dec 11, 2013
FDA report date
Jan 29, 2014
Quantity
249,096 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
KVK-Tech, Inc.

Original FDA data

Every field from FDA enforcement report D-1031-2014, exactly as published.

Show all FDA fields
City
Newtown
State
PA
Status
Terminated
Country
United States
Event ID
67103
Address
110 Terry Dr
Address (line 2)
Suite 200
Code information
NDC: 10702-011-01: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot # 10789, exp.May-14; lot #10790, exp. Jun-14; lot # 10791, exp. Jun-14: lot # 10792, exp. Aug-14; lot #10983, exp. Sep-14; lot #10984, exp.Sep-14; lot #10986, exp. Oct-14; lot # 11034, exp. Nov-14; lot #11035, exp. Dec-14; lot # 11036, exp. Dec-14; lot #11435, exp. Nov-15. NDC: 10702-011-10: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot #10789, exp. May-14; lot #10790, exp. Jun-14; lot #10791, exp. Jun-14; lot #10792, exp. Aug-14; lot # 10983, exp. Sep-14; lot #10985, exp. Oct-14; lot #11034, exp. Nov-14; lot #11038, exp. Dec-14; lot #11435, exp. Nov-15. NDC: 10702-011-50: lot #10666, exp. Feb-14; lot #10733, exp. May-14; lot # 10789, exp. May-14; lot #10791, exp. Jun-14; lot# 10792, exp. Aug-14; lot # 10983, exp. Sep-14; lot # 10985, exp. Oct-14; lot # 10986, exp. Oct-14; lot # 11037, exp. Dec-14; lot #11435, exp. Nov-15.
Postal code
18940-3427
Report date
Jan 29, 2014
Product type
Drugs
Recall number
D-1031-2014
Classification
Class II
Recalling firm
KVK-Tech, Inc.
Product quantity
249,096 bottles
Termination date
Aug 3, 2015
Reason for recall
Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.
Voluntary / mandated
Voluntary: Firm initiated
Product description
HydrOXYzine HCI Tablets USP 25 mg, 100, 500, and 1000 count bottles, Rx only. Mfd by: KVK-TECH, INC, Newtown, PA 18940. 100 count NDC: 10702-011-01, 500 count NDC: 10702-011-50, 1000 count NDC: 10702-011-10.
Distribution pattern
Nationwide, including Puerto Rico to wholesale distributors for sale to retail establishments.
Recall initiation date
Dec 11, 2013
Initial firm notification
Letter
Center classification date
Jan 22, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1031-2014, published Jan 29, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls